Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- Accepted/In press
Big Data, IPRs & Competition Law in the Pharma & Life Sciences- future issues in a rapidly evolving field.
Minssen, Timo, 2017, (Accepted/In press).Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
- Published
Biosimilars- A European perspective
Minssen, Timo, 2018.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
- Published
Book Review: Drexl, J., Lee, N. (2013). Pharmaceutical Innovation, Competition and Patent Law : A Trilateral Perspective. Edward Elgar Publishing
Minssen, Timo, 2014, In: E C L R: European Competition Law Review. 35, 4, p. 202-206 5 p.Research output: Contribution to journal › Literature review › Research › peer-review
- Published
Bumps on the Road Towards Clinical Trials Data Transparency- A recent U-Turn by the EMA?
Minssen, Timo, 3 Jun 2014Research output: Other contribution › Net publication - Internet publication › Research
- Published
CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and regulatory considerations
Pacia, D. M., Brown, B. L., Minssen, Timo & Darrow, J. J., 1 Jan 2024, In: Journal of Law and the Biosciences. 11, 1, lsad030.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Challenges for the sustainability of university-run biobanks
Kongsholm, Nana Cecilie Halmsted, Christensen, Søren Tvorup, Herrmann, Janne Rothmar, Larsen, Lars Allan, Minssen, Timo, Pedersen, Lotte Bang, Rajam, N., Tommerup, Niels, Tupasela, A. M. & Schovsbo, Jens Hemmingsen, 2018, In: Biopreservation and Biobanking. 16, 4, p. 312-321 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Clashes between clinical trials data transparency, IPRs, trade secrets & the protection of personal data: What does it mean for precision medicine?
Minssen, Timo, 12 Jun 2017.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
- Published
Clearing a way through the CRISPR patent jungle
Minssen, Timo, Van Zimmeren, E. & Wested, Jakob, 2018, In: Life Sciences Intellectual Property Review (LSIPR). 8/5 2018, 4 p.Research output: Contribution to journal › Journal article › Research
- Published
Clinical trials data transparency & GDPR compliance: What are the effects on data sharing and open innovation?
Minssen, Timo, Rajam, N. & Bogers, Marcel, 4 Apr 2020, In: Science and Public Policy. 47, 5, p. 616-626 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Collaboration in Times of Crisis: A Study on COVID-19 Vaccine R&D Partnerships
Druedahl, Louise C., Minssen, Timo & Price II, W. N., 8 Oct 2021, In: Vaccine. 39, 42, p. 6291 - 6295Research output: Contribution to journal › Journal article › Research › peer-review
ID: 16150437
Most downloads
-
4329
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2188
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2078
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published